BECN1 and prostate cancer: However, it has not been reported in prostate cancer bone metastasis patients.[12] Understanding the mechanisms of the AMPK/Beclin-1 pathway and its role in regulating cellular autophagy could reduce the severity and progression of prostate cancer bone metastasis, leading to improved treatment strategies.